Skip to content

Márcia Carvalho

Cooperativa de Ensino Superior Politécnico e Universitário

2 papers in the library · 367 citations · publishing 2004-2015

Papers

The hallucinogenic world of tryptamines: an updated review.

Archives of toxicology August 1, 2015 Ana Margarida Araújo, Félix Carvalho, Maria de Lourdes Bastos et al. 290 citations

Tryptamines are a broad class of hallucinogens that act primarily as agonists of the 5-HT2A receptor, producing profound changes in sensory perception, mood, and thought. Historically, natural tryptamines like psilocybin and DMT have been used in ritual contexts, but synthetic tryptamines such as AMT, 5-MeO-DMT, and 5-MeO-DIPT have recently emerged as recreational drugs, often sold as 'research chemicals' online. Reports of intoxication and deaths have raised international concern, though the lack of pharmacological and toxicological data hampers assessment of their public health harm. This review covers historical background, prevalence, patterns of use, legal status, chemistry, toxicokinetics, toxicodynamics, and physiological and toxicological effects in animals and humans.

Metabolism Is Required for the Expression of Ecstasy-Induced Cardiotoxicity in Vitro

Chemical Research in Toxicology April 27, 2004 Márcia Carvalho, Fernando Remião, Nuno Milhazes et al. 77 citations

MDMA (ecstasy) and its major metabolite MDA did not directly damage heart cells from adult rats in the lab, but two further metabolites, N-Me-alpha-MeDA and alpha-MeDA, caused significant toxicity. These catechol metabolites triggered a loss of normal cell shape, depletion of the antioxidant glutathione, sustained increases in intracellular calcium, drops in ATP, and reduced activity of antioxidant enzymes. N-Me-alpha-MeDA was the most toxic. The findings suggest that MDMA must be metabolized into these catechol compounds for cardiotoxicity to occur in isolated heart cells.